NGeneBio Co., Ltd. (KOSDAQ: 354200)
South Korea
· Delayed Price · Currency is KRW
3,175.00
-225.00 (-6.62%)
Oct 11, 2024, 9:00 AM KST
NGeneBio Revenue
NGeneBio had revenue of 2.03B KRW in the quarter ending June 30, 2024, with 127.98% growth. This brings the company's revenue in the last twelve months to 4.99B, down -16.14% year-over-year. In the year 2023, NGeneBio had annual revenue of 4.35B, down -60.51%.
Revenue (ttm)
4.99B
Revenue Growth
-16.14%
P/S Ratio
8.17
Revenue / Employee
48.91M
Employees
102
Market Cap
40.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.35B | -6.67B | -60.51% |
Dec 31, 2022 | 11.02B | 3.85B | 53.81% |
Dec 31, 2021 | 7.16B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition